Acquisition, In-Licensing Arrangement, Sale of Investment, Research and Development Arrangement and Collaborative Arrangement - In-Licensing Arrangement (Details) $ in Millions |
1 Months Ended |
|---|---|
|
Feb. 28, 2026
USD ($)
| |
| Sciwind Biosciences [Member] | In-Licensing Agreement [Member] | |
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Upfront, regulatory and sales milestone payments | $ 495 |